Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

A multivariate discrete failure time model for the analysis of infant motor development.

Neelon B, Shoaibi A, Benjamin-Neelon SE.

Stat Med. 2018 Nov 28. doi: 10.1002/sim.8055. [Epub ahead of print]

PMID:
30484904
2.

Research participation preferences as expressed through a patient portal: implications of demographic characteristics.

Obeid JS, Shoaibi A, Oates JC, Habrat ML, Hughes-Halbert C, Lenert LA.

JAMIA Open. 2018 Oct;1(2):202-209. doi: 10.1093/jamiaopen/ooy034. Epub 2018 Aug 16.

3.

The association between method of solicitation and patient permissions for use of surplus tissues and contact for future research.

Shoaibi A, Obeid JS, Oates JC, Habrat ML, Lenert LA.

JAMIA Open. 2018 Oct;1(2):195-201. doi: 10.1093/jamiaopen/ooy038. Epub 2018 Sep 24.

4.

Household chaos during infancy and infant weight status at 12 months.

Khatiwada A, Shoaibi A, Neelon B, Emond JA, Benjamin-Neelon SE.

Pediatr Obes. 2018 Oct;13(10):607-613. doi: 10.1111/ijpo.12395. Epub 2018 Jul 17.

5.

Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease.

Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA.

Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):872-877. doi: 10.1002/pds.4583. Epub 2018 Jun 22.

PMID:
29932281
6.

Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Zheng J, Merchant AT, Wirth MD, Zhang J, Antwi SO, Shoaibi A, Shivappa N, Stolzenberg-Solomon RZ, Hebert JR, Steck SE.

Int J Cancer. 2018 Jun 15;142(12):2461-2470. doi: 10.1002/ijc.31271. Epub 2018 Feb 2.

PMID:
29355939
7.

Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.

Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10.

PMID:
29318683
8.

Equilibrium model analysis of waste plastics gasification using CO2 and steam.

Kannan P, Lakshmanan G, Al Shoaibi A, Srinivasakannan C.

Waste Manag Res. 2017 Dec;35(12):1247-1253. doi: 10.1177/0734242X17736946. Epub 2017 Nov 3.

PMID:
29100482
9.

A population-based approach for implementing change from opt-out to opt-in research permissions.

Marshall EA, Oates JC, Shoaibi A, Obeid JS, Habrat ML, Warren RW, Brady KT, Lenert LA.

PLoS One. 2017 Apr 25;12(4):e0168223. doi: 10.1371/journal.pone.0168223. eCollection 2017.

10.

Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk.

Flory JH, Roy J, Gagne JJ, Haynes K, Herrinton L, Lu C, Patorno E, Shoaibi A, Raebel MA.

J Comp Eff Res. 2017 Jan;6(1):25-32. doi: 10.2217/cer-2016-0033. Epub 2016 Dec 9.

PMID:
27935320
11.

Food wastes derived adsorbents for carbon dioxide and benzene gas sorption.

Opatokun SA, Prabhu A, Al Shoaibi A, Srinivasakannan C, Strezov V.

Chemosphere. 2017 Feb;168:326-332. doi: 10.1016/j.chemosphere.2016.10.083. Epub 2016 Oct 27.

PMID:
27810531
12.

A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data.

Nelson JC, Wellman R, Yu O, Cook AJ, Maro JC, Ouellet-Hellstrom R, Boudreau D, Floyd JS, Heckbert SR, Pinheiro S, Reichman M, Shoaibi A.

EGEMS (Wash DC). 2016 Sep 6;4(1):1219. eCollection 2016.

13.

Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer.

Shoaibi A, Rao GA, Cai B, Rawl J, Haddock KS, Hébert JR.

Prostate. 2017 Feb;77(2):173-184. doi: 10.1002/pros.23258. Epub 2016 Oct 4.

PMID:
27699819
14.

A Facile Synthesis of Mesoporous Sulfonated Carbon and Its Structural Properties.

Prabhu A, Al Shoaibi A, Srinivasakannan C.

J Nanosci Nanotechnol. 2016 Jan;16(1):1202-6.

PMID:
27398587
15.

Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected.

Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J.

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):798-814. doi: 10.1002/pds.4015. Epub 2016 May 4.

PMID:
27146273
16.

Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.

Critchley J, Capewell S, O'Flaherty M, Abu-Rmeileh N, Rastam S, Saidi O, Sözmen K, Shoaibi A, Husseini A, Fouad F, Ben Mansour N, Aissi W, Ben Romdhane H, Unal B, Bandosz P, Bennett K, Dherani M, Al Ali R, Maziak W, Arık H, Gerçeklioğlu G, Altun DU, Şimşek H, Doganay S, Demiral Y, Aslan Ö, Unwin N, Phillimore P; MedCHAMPS; This publication was prepared with support from and on behalf of the MedCHAMPS consortium members, Achour N, Aissi W, Allani R, Arfa C, Abu-Kteish H, Abu-Rmeileh N, Al Ali R, Altun D, Ahmad B, Arık H, Aslan Ö, Beltaifa L, Ben Mansour N, Bennett K, Ben Romdhane H, Ben Salah N, Collins M, Critchley J, Capewell S, Dherani M, Demiral Y, Doganay S, Elias M, Ergör G, Fadhil I, Fouad F, Gerçeklioğlu G, Ghandour R, Göğen S, Husseini A, Jaber S, Kalaca S, Khatib R, Khatib R, Koudsie S, Kilic B, Lassoued O, Mason H, Maziak W, Mayaleh MA, Mikki N, Moukeh G, Flaherty MO, Phillimore P, Rastam S, Roglic G, Saidi O, Saatli G, Satman I, Shoaibi A, Şimşek H, Soulaiman N, Sözmen K, Tlili F, Unal B, Unwin N, Yardim N, Zaman S.

Int J Cardiol. 2016 Apr 1;208:150-61. doi: 10.1016/j.ijcard.2016.01.031. Epub 2016 Jan 7.

PMID:
26878275
17.

Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring.

Xu S, Shetterly S, Cook AJ, Raebel MA, Goonesekera S, Shoaibi A, Roy J, Fireman B.

Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):453-61. doi: 10.1002/pds.3983. Epub 2016 Feb 15.

18.

The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Shoaibi A, Rao GA, Cai B, Rawl J, Hébert JR.

Ann Epidemiol. 2016 Jan;26(1):36-42.e1-2. doi: 10.1016/j.annepidem.2015.10.003. Epub 2015 Oct 28.

19.

Synthesis of porous sulfonated carbon as a potential adsorbent for phenol wastewater.

Prabhu A, Al Shoaibi A, Srinivasakannan C.

Water Sci Technol. 2015;72(9):1594-600. doi: 10.2166/wst.2015.372.

PMID:
26524451
20.

Reaction Mechanism for m-Xylene Oxidation in the Claus Process by Sulfur Dioxide.

Sinha S, Raj A, Al Shoaibi AS, Chung SH.

J Phys Chem A. 2015 Sep 24;119(38):9889-900. doi: 10.1021/acs.jpca.5b06020. Epub 2015 Sep 10.

PMID:
26334187
21.

Using linked electronic data to validate algorithms for health outcomes in administrative databases.

Lee WJ, Lee TA, Pickard AS, Shoaibi A, Schumock GT.

J Comp Eff Res. 2015 Aug;4(4):359-66. doi: 10.2217/cer.15.14.

PMID:
26274797
22.

KOH-based porous carbon from date palm seed: preparation, characterization, and application to phenol adsorption.

Suresh Kumar Reddy K, Kannan P, Al Shoaibi A, Srinivasakannan C.

Water Sci Technol. 2014;70(10):1633-40. doi: 10.2166/wst.2014.419.

PMID:
25429451
23.

Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.

Bell C, Chakravarty A, Gruber S, Heckbert SR, Levenson M, Martin D, Nelson JC, Pinheiro S, Psaty BM, Reich CG, Schneeweiss S, Shoaibi A, Toh S, Walker AM.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1223-5. doi: 10.1002/pds.3712. Epub 2014 Sep 29. No abstract available.

PMID:
25263307
24.

Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four eastern Mediterranean countries.

Ghandour R, Shoaibi A, Khatib R, Abu Rmeileh N, Unal B, Sözmen K, Kılıç B, Fouad F, Al Ali R, Ben Romdhane H, Aissi W, Ahmad B, Capewell S, Critchley J, Husseini A.

Int J Public Health. 2015 Jan;60 Suppl 1:S73-81. doi: 10.1007/s00038-014-0569-3. Epub 2014 May 31.

PMID:
24879318
25.

Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.

Rao GA, Mann JR, Shoaibi A, Bennett CL, Nahhas G, Sutton SS, Jacob S, Strayer SM.

Ann Fam Med. 2014 Mar-Apr;12(2):121-7. doi: 10.1370/afm.1601.

26.

Elemental mercury adsorption on sulfur-impregnated porous carbon - a review.

Reddy KS, Shoaibi AA, Srinivasakannan C.

Environ Technol. 2014 Jan-Feb;35(1-4):18-26. Review.

PMID:
24600836
27.

A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.

Mason H, Shoaibi A, Ghandour R, O'Flaherty M, Capewell S, Khatib R, Jabr S, Unal B, Sözmen K, Arfa C, Aissi W, Ben Romdhane H, Fouad F, Al-Ali R, Husseini A; MedCHAMPS project team.

PLoS One. 2014 Jan 7;9(1):e84445. doi: 10.1371/journal.pone.0084445. eCollection 2014.

28.

Drug risk assessment and data reuse.

Iyasu S, Staffa J, Graham D, Shoaibi A, Levenson M, Chakravarty A, Hammad TA.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):107-8. doi: 10.1002/pds.3518. No abstract available.

PMID:
24395549
29.

Response to the letter by Mol.

Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):106. doi: 10.1002/pds.3519. No abstract available.

PMID:
24395548
30.

Mini-Sentinel methods: framework for assessment of positive results from signal refinement.

McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):3-8. doi: 10.1002/pds.3547. Epub 2013 Nov 25. No abstract available.

PMID:
24395545
31.

Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.

Mosholder AD, Racoosin JA, Young S, Wernecke M, Shoaibi A, MaCurdy TE, Worrall C, Kelman JA.

Ann Pharmacother. 2013 Nov;47(11):1420-8. doi: 10.1177/1060028013500940.

PMID:
24285759
32.

Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel.

Walsh KE, Cutrona SL, Foy S, Baker MA, Forrow S, Shoaibi A, Pawloski PA, Conroy M, Fine AM, Nigrovic LE, Selvam N, Selvan MS, Cooper WO, Andrade S.

Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1205-13. doi: 10.1002/pds.3505. Epub 2013 Sep 5.

33.

Health system challenges of cardiovascular disease and diabetes in four Eastern Mediterranean countries.

Phillimore P, Zaman S, Ahmad B, Shoaibi A, Khatib R, Khatib R, Husseini A, Fouad F, Elias M, Maziak W, Tlili F, Tinsa F, Ben Romdhane H, Kılıç B, Kalaça S, Ünal B, Critchley J.

Glob Public Health. 2013;8(8):875-89. doi: 10.1080/17441692.2013.830756. Epub 2013 Sep 5.

PMID:
24004405
34.

Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.

Toh S, Reichman ME, Houstoun M, Ding X, Fireman BH, Gravel E, Levenson M, Li L, Moyneur E, Shoaibi A, Zornberg G, Hennessy S.

Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1171-7. doi: 10.1002/pds.3483. Epub 2013 Jul 23.

PMID:
23878013
35.

A critical review of methods to evaluate the impact of FDA regulatory actions.

Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):986-94. doi: 10.1002/pds.3480. Epub 2013 Jul 12. Review.

36.

Angiotensin receptor blockers: are they related to lung cancer?

Rao GA, Mann JR, Shoaibi A, Pai SG, Bottai M, Sutton SS, Haddock KS, Bennett CL, Hebert JR.

J Hypertens. 2013 Aug;31(8):1669-75. doi: 10.1097/HJH.0b013e3283621ea3.

37.

Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database.

Lo Re V 3rd, Haynes K, Goldberg D, Forde KA, Carbonari DM, Leidl KB, Hennessy S, Reddy KR, Pawloski PA, Daniel GW, Cheetham TC, Iyer A, Coughlin KO, Toh S, Boudreau DM, Selvam N, Cooper WO, Selvan MS, VanWormer JJ, Avigan MI, Houstoun M, Zornberg GL, Racoosin JA, Shoaibi A.

Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):861-72. doi: 10.1002/pds.3470. Epub 2013 Jun 25.

38.

Use of evidence to support healthy public policy: a policy effectiveness-feasibility loop.

Bowman S, Unwin N, Critchley J, Capewell S, Husseini A, Maziak W, Zaman S, Ben Romdhane H, Fouad F, Phillimore P, Unal B, Khatib R, Shoaibi A, Ahmad B.

Bull World Health Organ. 2012 Nov 1;90(11):847-53. doi: 10.2471/BLT.12.104968. Epub 2012 Sep 14.

39.

Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.

Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S.

Arch Intern Med. 2012 Nov 12;172(20):1582-9. doi: 10.1001/2013.jamainternmed.34. Erratum in: Arch Intern Med. 2013 Jan 14;173(1):14.

PMID:
23147456
40.

Analysing falls in coronary heart disease mortality in the West Bank between 1998 and 2009.

Abu-Rmeileh NM, Shoaibi A, O'Flaherty M, Capewell S, Husseini A.

BMJ Open. 2012 Aug 24;2(4). pii: e001061. doi: 10.1136/bmjopen-2012-001061. Print 2012.

41.

When should case-only designs be used for safety monitoring of medical products?

Maclure M, Fireman B, Nelson JC, Hua W, Shoaibi A, Paredes A, Madigan D.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:50-61. doi: 10.1002/pds.2330.

PMID:
22262593
42.

Expert panel consensus recommendations for the pharmacological treatment of acute pain in the Middle East region.

Ayad AE, Ghaly N, Ragab R, Majeed S, Nassar H, Al Jalabi A, Al Shoaibi A, El Noor S, Salti A, Costandi J, Zeidan AZ, Schug SA.

J Int Med Res. 2011;39(4):1123-41. Erratum in: J Int Med Res. 2011;39(5):2059.

PMID:
21986115
43.

Kinetic modeling of ethane pyrolysis at high conversion.

Xu C, Al Shoaibi AS, Wang C, Carstensen HH, Dean AM.

J Phys Chem A. 2011 Sep 29;115(38):10470-90. doi: 10.1021/jp206503d. Epub 2011 Aug 31.

PMID:
21848278
44.

Making the future ours in the occupied Palestinian territory.

Ayesh A, Yahya A, Qara' AA, Dababat A, Hadeed AA, Shoaibi A, Mahmoud DA, Issa F, Qaisi F, Hasan F, Saadeh H, Alami H, El Hadi H, Hamda HA, Al Kawazba L, Ya'qoub M, Hannoon M, Ibrahim M, Bsiso M, Jarar M, Daraghmeh M, Fahmawi N, Saeed NH, Harhash N, Darwish N, Omar O, Shu'ibi R, E Hazineh R, Safat RA, Shraim R, Shamasna S, Odeh SB, Shamasneh S, Al Haj Ali S, Mitwali S.

Lancet. 2010 Jul 3;376(9734):8-10. doi: 10.1016/S0140-6736(10)60968-3. No abstract available.

PMID:
20609978
45.

Gender differences in the treatment of non-ST-segment elevation myocardial infarction.

Tavris D, Shoaibi A, Chen AY, Uchida T, Roe MT, Chen J.

Clin Cardiol. 2010 Feb;33(2):99-103. doi: 10.1002/clc.20691.

46.

Gender differences in correlates of troponin assay in diagnosis of myocardial infarction.

Shoaibi A, Tavris DR, McNulty S.

Transl Res. 2009 Nov;154(5):250-6. doi: 10.1016/j.trsl.2009.07.004. Epub 2009 Aug 3.

PMID:
19840766
47.

Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase-2.

Palayoor ST, Arayankalayil MJ, Shoaibi A, Coleman CN.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6980-6.

48.

Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes.

Gardner MJ, Bishop R, Shah T, de Villiers EP, Carlton JM, Hall N, Ren Q, Paulsen IT, Pain A, Berriman M, Wilson RJ, Sato S, Ralph SA, Mann DJ, Xiong Z, Shallom SJ, Weidman J, Jiang L, Lynn J, Weaver B, Shoaibi A, Domingo AR, Wasawo D, Crabtree J, Wortman JR, Haas B, Angiuoli SV, Creasy TH, Lu C, Suh B, Silva JC, Utterback TR, Feldblyum TV, Pertea M, Allen J, Nierman WC, Taracha EL, Salzberg SL, White OR, Fitzhugh HA, Morzaria S, Venter JC, Fraser CM, Nene V.

Science. 2005 Jul 1;309(5731):134-7.

49.

The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)-an assessment of the literature.

Tavris DR, Shoaibi A.

Diabetes Technol Ther. 2004 Aug;6(4):518-22. Review.

PMID:
15321009
50.

Supplemental Content

Loading ...
Support Center